Having established functional and mechanistic roles for GRB2 during RF stress that restrict inflammatory cytokine release, we directly investigated immune surveillance of PARPi-treated cancer cells with low GRB2 in a whole animal setting. This evidence concerns the gene GRB2 and cancer.